Retatrutide, by Soma Chems , represents a significant advance in metabolic regulation. This unique compound combines incretin receptor agonist function with gut-derived receptor engagement, showing remarkable efficacy in patient studies for body reduction . Researchers believe this treatment may represent a alternative option for patients facing ex